Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis
  Free Subscription

Articles published in
J Viral Hepat
    December 2026
  1. LIU L, Li M, Zhu S, Dong Y, et al
    Real-World Effectiveness and Safety of Sofosbuvir-Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study.
    J Viral Hepat. 2026;33:e70253.
    >> Share

  2. DEBNATH M, Jayaswal RP
    From Detecting Lesions to Delivering Care: Point-of-Care Ultrasound in Hepatitis B.
    J Viral Hepat. 2026;33:e70256.
    >> Share

    November 2026
  3. REN J, Ji R, Zhu Z, Ren X, et al
    Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021.
    J Viral Hepat. 2026;33:e70236.
    >> Share

  4. GUNASEKARAN V, Arun Babu T
    Can Point-of-Care Ultrasound for Hepatitis (PUSH) Protocol Be Considered an HCC Screening Tool? Methodological Considerations From a Validation Study.
    J Viral Hepat. 2026;33:e70239.
    >> Share

  5. GOMEZ DP, Hababag WF
    Finite Versus Indefinite Nucleos(t)ide Analogue Therapy in HBeAg?Negative Chronic Hepatitis B: Meta?Analysis of Randomized Trials.
    J Viral Hepat. 2026;33:e70243.
    >> Share

  6. SATO S, Yamaguchi M, Nago H, Kato Y, et al
    Direct-Acting Antiviral Therapy in Patients With Hepatocellular Carcinoma Receiving Non-Curative Treatment: High Sustained Virological Response Rates and Preservation of Liver Functional Reserve.
    J Viral Hepat. 2026;33:e70242.
    >> Share

  7. CHABALA FW, Sinkala E, Brennan AT, Goss AM, et al
    Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance.
    J Viral Hepat. 2026;33:e70241.
    >> Share

  8. SONG BG, Lee M, Cho J, Gwak GY, et al
    Becoming Physically Active and Risks of Mortality and Liver-Related Events in Adults With Chronic Hepatitis B: A Nationwide Cohort Study.
    J Viral Hepat. 2026;33:e70240.
    >> Share

  9. KUDARAVALLI S, Yan T, Tseng CH, Hsu YC, et al
    Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients.
    J Viral Hepat. 2026;33:e70245.
    >> Share

  10. HURRY E, Hulse S, Hughes A
    New Model of Care Achieving Micro-Elimination of Hepatitis C in the United Kingdom's Largest Prison.
    J Viral Hepat. 2026;33:e70244.
    >> Share

  11. UOJIMA H, Huang R, Trinh H, Nozaki A, et al
    Similar Long-Term Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Initiating Entecavir Versus Tenofovir Alafenamide: A REAL-B Study.
    J Viral Hepat. 2026;33:e70250.
    >> Share

  12. PACK K, Yousaf M, Wattick RA, Armstrong B, et al
    Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022-2023.
    J Viral Hepat. 2026;33:e70247.
    >> Share

  13. MUTIMER D, Latham E, Atabani SF, Ijaz S, et al
    Hepatitis A Virus (HAV) Recurrence and De Novo Hepatitis A Acquired at Time of Liver Transplantation: Comparison of Graft HAV Infection and Viral Kinetics.
    J Viral Hepat. 2026;33:e70248.
    >> Share

  14. ASSELAH T, Kakuda TN, Kulke S, Walenta E, et al
    A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B.
    J Viral Hepat. 2026;33:e70246.
    >> Share

  15. REN D, Dang X, Fu S, Zhang Z, et al
    Renal Safety and Antiviral Effectiveness of Tenofovir Alafenamide Versus Entecavir in Patients With Chronic Hepatitis B and Chronic Kidney Disease: A Real-World Cohort Study.
    J Viral Hepat. 2026;33:e70235.
    >> Share

  16. HAN WM, Solomon S, Wagner-Cardoso S, Li J, et al
    Rare and Novel Hepatitis C Virus Genotype Subtypes and Response to Sofosbuvir/Velpatasvir in A5360 (MINMON) Clinical Trial.
    J Viral Hepat. 2026;33:e70251.
    >> Share

    October 2026
  17. ARIUNGEREL N, Otgonbaatar K, Enkhjargal S, Erdembileg U, et al
    A Novel Quantitative ELISA Demonstrates Lack of Correlation Between Serum HDV-RNA and Anti-HDV Antibody Levels in Chronic HDV Infection.
    J Viral Hepat. 2026;33:e70227.
    >> Share

  18. CARSON JM, Barbieri S, Verich A, Tu E, et al
    Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response.
    J Viral Hepat. 2026;33:e70229.
    >> Share

  19. WHITTAKER R, Wusthoff LC, Midtbo JE, Midgard H, et al
    Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway.
    J Viral Hepat. 2026;33:e70202.
    >> Share

  20. BRASIL S, Ribeiro-Alves M, Villela-Nogueira C, Silva SDCC, et al
    Optimizing the HCV Care Continuum in Primary Care: Opportunistic Screening With Point-Of-Care RNA Testing and Immediate Linkage-To-Care in Rio de Janeiro, Brazil.
    J Viral Hepat. 2026;33:e70234.
    >> Share

  21. ETOORI D, Powell A, Trembling P, Plunkett J, et al
    Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case-Notes Review.
    J Viral Hepat. 2026;33:e70228.
    >> Share

  22. ZHANG X, Yue C
    Interpreting Risk Factors in Hepatitis C Virus-Associated Hepatocellular Carcinoma.
    J Viral Hepat. 2026;33:e70231.
    >> Share

  23. FATIMA N, Elle A
    Beyond Virological Response: Refining the Assessment of Clinical and Patient-Reported Outcomes in Bulevirtide Therapy for Chronic Hepatitis D.
    J Viral Hepat. 2026;33:e70233.
    >> Share

  24. ROSSOTTI R, Tavelli A, Malagnino V, Svicher V, et al
    Persistent ALT Elevation and Liver Outcomes After DAA-Induced HCV Cure in People With HIV: Impact of HBV and HDV Co-Infections.
    J Viral Hepat. 2026;33:e70230.
    >> Share

    September 2026
  25. KITA Y, Murata A, Nago H, Yamaguchi M, et al
    Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients.
    J Viral Hepat. 2026;33:e70218.
    >> Share

  26. MALIKI I, Webb EJD, Ada RA, Dawkins B, et al
    Prevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70219.
    >> Share

  27. BERTONI C, Kanunga A, Sinkala E, Syabbalo E, et al
    Validation of a Point-Of-Care Ultrasound for Hepatitis Among Front-Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia.
    J Viral Hepat. 2026;33:e70216.
    >> Share

  28. LAMPERTICO P, Gish RG, Reau N, Wedemeyer H, et al
    The Impact of Chronic Hepatitis D Virus Infection on Health-Related Quality of Life and Fatigue: A Real-World International Study.
    J Viral Hepat. 2026;33:e70193.
    >> Share

  29. TKACHUK B, Couloigner I, Coffin CS, Jiang J, et al
    Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population-Based Spatial Analysis.
    J Viral Hepat. 2026;33:e70223.
    >> Share

  30. SHIEL EV, George B, Verma A, Gasteiger N, et al
    Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.
    J Viral Hepat. 2026;33:e70221.
    >> Share

  31. SIMMONS R, Ijaz S, Jackson R, Jack K, et al
    Characterising Hepatitis D Virus in the UK From 2011 to 2021.
    J Viral Hepat. 2026;33:e70205.
    >> Share

  32. CARGILL Z, Lok J, Dusheiko G, Carey I, et al
    Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review.
    J Viral Hepat. 2026;33:e70225.
    >> Share

  33. ZHOU Y, Xiong F, Chen J, Liu X, et al
    A New Nomogram for Mortality Prediction Within 5 Years in Portal Vein Thrombosis due to Hepatitis B-Related Cirrhosis.
    J Viral Hepat. 2026;33:e70220.
    >> Share

  34. AGARWAL K, Forton D, Zen Y, Wu M, et al
    ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.
    J Viral Hepat. 2026;33:e70224.
    >> Share

  35. ZHENG S, Li X, Liu H, Mao T, et al
    Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study.
    J Viral Hepat. 2026;33:e70226.
    >> Share

    August 2026
  36. BARRANCO MA, Shufelt S, Flanigan C, Wilberschied L, et al
    Integrated Studies of Infectious Disease Elimination (InSIDE): Hepatitis C Antibody and RNA Status of Persons Who Inject Drugs in New York State, 2021-2023.
    J Viral Hepat. 2026;33:e70208.
    >> Share

  37. MACLACHLAN JH, Romero N, Rowe SL, Allard N, et al
    Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study.
    J Viral Hepat. 2026;33:e70207.
    >> Share

  38. WONG RJ, Yang Z, Cheung R
    Hepatocellular Carcinoma Risk Between Untreated Immune Tolerant Vs. Treated Immune Active Chronic Hepatitis B Patients.
    J Viral Hepat. 2026;33:e70204.
    >> Share

  39. MOUSSA D, Wallace J, Richmond J, Doyle JS, et al
    Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in Australia.
    J Viral Hepat. 2026;33:e70203.
    >> Share

  40. VAN STRATEN CGJI, van Benthem BHB, van der Klis FRM, Smits G, et al
    Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys.
    J Viral Hepat. 2026;33:e70213.
    >> Share

  41. SUOH M, Esmaili S, Eslam M, George J, et al
    Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.
    J Viral Hepat. 2026;33:e70206.
    >> Share

  42. HUI RW, Wong DK, Fung J, Cheung KS, et al
    Droplet Digital PCR Measurement of HBV DNA in On-Treatment Chronic HBV Patients: Association With HCC Development and Outcomes.
    J Viral Hepat. 2026;33:e70209.
    >> Share

  43. ETOORI D, Simmons R, Powell A, Desai M, et al
    Trends in Mortality After the Roll-Out of Directly Acting Antivirals for Hepatitis C in England Using Linked Surveillance Data.
    J Viral Hepat. 2026;33:e70210.
    >> Share

  44. ZHAO J, Lewis D, Gamble JM, Butt ZA, et al
    An Exploratory Cost-Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D.
    J Viral Hepat. 2026;33:e70214.
    >> Share

  45. NISHIYA AS, Alencar CS, Gouvea MSG, Ono SK, et al
    Absence of Detectable Anti-HDV Antibodies Among HBsAg-Positive Blood Donors, HIV-Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay.
    J Viral Hepat. 2026;33:e70217.
    >> Share

  46. HALL S, Ocama P, Leavelle D, Kiwanuka J, et al
    Prevention of HBV Mother-To-Child Transmission (MTCT) Using Targeted HBV Birth Dose, and Treatment of High Viral Load Pregnant Women in Uganda.
    J Viral Hepat. 2026;33:e70215.
    >> Share

  47. SMITH V, Asriah M, Fernelius K, Das J, et al
    The Silent Burden of Hepatitis B-Related Stigma.
    J Viral Hepat. 2026;33:e70212.
    >> Share

  48. TAYE BW, Valery PC, Strasser SI, Weltman M, et al
    Differing Epidemiology of Chronic Hepatitis C Infection, Treatment, and Outcomes Among Migrants and Australian-Born Patients.
    J Viral Hepat. 2026;33:e70211.
    >> Share

    July 2026
  49. LOPEZ A, Gopalakrishna H, Chang S, Manhas S, et al
    Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States.
    J Viral Hepat. 2026;33:e70186.
    >> Share

  50. D'AMORE A, Sirajuddin A, George N, Ahlman M, et al
    Cardiac MRI Identifies Subclinical Myocardial Tissue Abnormalities in Individuals With Hepatitis C Regardless of Myocardial Damage Markers or Fibrosis Stage.
    J Viral Hepat. 2026;33:e70197.
    >> Share

  51. RAINS A, Almirol E, Nicholson W, Fletcher S, et al
    Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs.
    J Viral Hepat. 2026;33:e70200.
    >> Share

  52. DRAPER BL, Naing MMS, Htay H, Flynn M, et al
    Assessing the Utility of Shortened Read Time of the Abbott Bioline HCV Test to Predict Viremia.
    J Viral Hepat. 2026;33:e70198.
    >> Share

  53. LAKIOTAKI D, Papatheodoridi M, Sevastianos V, Zachou K, et al
    HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.
    J Viral Hepat. 2026;33:e70201.
    >> Share

    June 2026
  54. SPENCER H, Brumbach B, Geduldig A, Nelson L, et al
    Low-Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire.
    J Viral Hepat. 2026;33:e70180.
    >> Share

  55. GRAHAM SS
    A Framework for Emergency Department-Integrated Hepatitis C Test-and-Treat in the United States.
    J Viral Hepat. 2026;33:e70178.
    >> Share

  56. CHEN LF, Wei LC
    Telemedicine for Low-Barrier Hepatitis C Care in Rural Patients With Substance Use Disorders: Lessons From Taiwan.
    J Viral Hepat. 2026;33:e70179.
    >> Share

  57. SINGSUNG K, Vorasittha A, Tangkijvanich P, Tanaka Y, et al
    Host Factors DDB2 and DNA Polymerase Delta Are Linked to cccDNA Persistence in Hepatitis B Virus and Occult Hepatitis B Virus-Related Hepatocellular Carcinoma.
    J Viral Hepat. 2026;33:e70182.
    >> Share

  58. NOVIELLO C, Arico M, Scazzi FL, Riformato G, et al
    Long-Term Persistence of Hepatitis A Virus Immunity in Healthcare Workers Upto 25 Years After Vaccination.
    J Viral Hepat. 2026;33:e70187.
    >> Share

  59. PRIVATO R, Pinon M, Buccella V, Corpino M, et al
    Clinical Course and Outcomes of Paediatric Chronic Hepatitis B: Insights From a Multicenter Longitudinal Cohort of 248 Patients.
    J Viral Hepat. 2026;33:e70183.
    >> Share

  60. MENGATO D, Battistella S, Cadore A, Giunco EM, et al
    Effectiveness, Safety and Patient-Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real-World Evidence From a Prospective Observational Study.
    J Viral Hepat. 2026;33:e70181.
    >> Share

  61. KESAVAN SM, Khan G, Jack K, Martello E, et al
    Interventions to Increase Hepatitis B Testing Uptake Amongst Detained Populations: A Systematic Review.
    J Viral Hepat. 2026;33:e70189.
    >> Share

  62. YILMAZ Y, Yu ML, Alswat K, El-Kassas M, et al
    Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.
    J Viral Hepat. 2026;33:e70188.
    >> Share

  63. DRYSDALE M, Chang R, Wang S, Coutinho A, et al
    Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection.
    J Viral Hepat. 2026;33:e70184.
    >> Share

  64. KLEINER BB, Meconnen M, Azar M, Minoyan N, et al
    Incidence of HIV and HCV Among People Who Inject Drugs in Montreal, Canada: Data From the HEPCO Longitudinal Cohort Study, 2011-2025.
    J Viral Hepat. 2026;33:e70185.
    >> Share

    May 2026
  65. HILL KC, Brinkley S, Latimer M, Tichnell P, et al
    Utilizing Telemedicine to Engage Rural Patients With Substance Use Disorders in Low Barrier Hepatitis C Treatment.
    J Viral Hepat. 2026;33:e70173.
    >> Share

  66. WEI N, Liu M, Cai H, Li N, et al
    Cost-Effectiveness of De Novo Combination of Tenofovir Alafenamide Fumarate and Peginterferon Alfa-2b Versus Peginterferon Alfa-2b Monotherapy of HBeAg-Positive Chronic Hepatitis B in China.
    J Viral Hepat. 2026;33:e70170.
    >> Share

  67. LEE SY, Shin HD
    Meta-Analysis of Genetic Variants Associated With HBV Infection Susceptibility and Hepatocellular Carcinoma Risk.
    J Viral Hepat. 2026;33:e70175.
    >> Share

  68. STARINIERI I, Chitnis A, Wong RJ, Yette E, et al
    Cost-Effectiveness of Interventions to Improve Retention in Care for Chronic Hepatitis B in the United States.
    J Viral Hepat. 2026;33:e70176.
    >> Share

    April 2026
  69. ROMERO-VICO J, Feliu A, Vargas-Accarino E, Sanchez-Gavilan E, et al
    Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA App.
    J Viral Hepat. 2026;33:e70160.
    >> Share

  70. JANG TY
    The Impact of Ambient Temperature on HCC Risk in Patients With Chronic Hepatitis B.
    J Viral Hepat. 2026;33:e70166.
    >> Share

  71. THOMADAKIS C, Gountas I, Gountas K, Nuno N, et al
    Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis.
    J Viral Hepat. 2026;33:e70159.
    >> Share

  72. DEMANT J, Soholm J, Lazarus JV, Krohn-Dehli L, et al
    Prevalence and Factors Associated With Hepatitis C in Danish Prisons, 2022-2024: A Multicentre Cross-Sectional Study.
    J Viral Hepat. 2026;33:e70154.
    >> Share

  73. NIYOMSRI S, Lim AG, Arif A, Asim M, et al
    The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional Study.
    J Viral Hepat. 2026;33:e70139.
    >> Share

  74. LI J, Xu X, Liu J, Li M, et al
    Prevalence, Clinical Presentation and Outcome of Hepatitis B Patients With Indeterminate Phase: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70161.
    >> Share

  75. SHAH S, Mafirakureva N, Trickey A, Hasnain A, et al
    Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan.
    J Viral Hepat. 2026;33:e70164.
    >> Share

  76. SHIBLI S, Suki M, Korzom T, Green MS, et al
    Hepatitis B Vaccine Response in Children of Vaccinated Versus Unvaccinated Mothers: A Retrospective Cohort Study.
    J Viral Hepat. 2026;33:e70165.
    >> Share

  77. XU J, Cao Y, Xiao Y, Li W, et al
    A New Model for Hepatitis C Elimination: CDC-Dispatching Follow-Up Coordinators Stationed in Hospitals.
    J Viral Hepat. 2026;33:e70163.
    >> Share

  78. FRAGA M, Kasmi S, Weber SN, Liebe R, et al
    Prolonged Intrahepatic Cholestasis After Acute Hepatitis E Infection: A Case Series and Genetic Analysis.
    J Viral Hepat. 2026;33:e70156.
    >> Share

  79. GUO L, Wu W, Zhou W, Liang R, et al
    Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China.
    J Viral Hepat. 2026;33:e70153.
    >> Share

  80. THOMPSON K, Thompson J, Miller LS
    Characteristics of Patients and Factors Associated With the Development of Hepatitis C Virus-Associated Hepatocellular Carcinoma in an Urban, Primary-Care Based Hepatitis C Clinic.
    J Viral Hepat. 2026;33:e70169.
    >> Share

  81. THAKUR HS, Yadav V
    Methodological Considerations in Prevalence Meta-Analysis of Hepatitis B Among Migrants.
    J Viral Hepat. 2026;33:e70171.
    >> Share

  82. HARRISON R, Patel S, Marra F, Francisco A, et al
    Co-Administration of Hepatitis C Direct-Acting Antivirals and Enzyme-Inducing Antiepileptic Drugs: Real-World Experience From a Multi-Centre Case Series.
    J Viral Hepat. 2026;33:e70168.
    >> Share

  83. CAVIGLIA GP, Stroffolini T
    Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge.
    J Viral Hepat. 2026;33:e70172.
    >> Share

  84. WANG DH, Wang JL, Jiang SW, Zhou AW, et al
    HBV RNA Predicts the Risk of Off-Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70167.
    >> Share

    March 2026
  85. LUO Q, Xu W, Zhang Y, Li X, et al
    Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.
    J Viral Hepat. 2026;33:e70141.
    >> Share

  86. POL S, Ouzan D, Cattan L
    HCV Cure: To Bridge the Gaps in the Care Continuum.
    J Viral Hepat. 2026;33:e70138.
    >> Share

  87. SILVEIRA IB, Silva GP, Sampaio AVH, Tome MR, et al
    Synchronous Telemedicine Versus In-Person Care in Hepatitis C Treatment: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70144.
    >> Share

  88. GARRIDO-ESTEPA M
    Impact of Direct-Acting Antivirals Availability on Hepatitis C-Related Hospitalisations After Eight Years of the Strategic Plan for Tackling Hepatitis C Implementation in Spain.
    J Viral Hepat. 2026;33:e70143.
    >> Share

  89. WONGSIRISAKUL P, Parikh ND, Troost J, Par H, et al
    A Community-Engaged Approach to Identifying and Addressing Viral Hepatitis Determinants in Michigan Asian American Communities.
    J Viral Hepat. 2026;33:e70149.
    >> Share

  90. GEBREHANA AK, Asnake AA, Seifu BL, Fente BM, et al
    Uptake of the Birth Dose HBV Vaccine and Associated Factors Among Children in Sub-Saharan Africa: An Analysis Using Recent Demographic and Health Survey Data.
    J Viral Hepat. 2026;33:e70147.
    >> Share

  91. DASHDORJ ED, Sereenendorj K, Ochirsum B, Bat-Ulzii P, et al
    Progress Towards Elimination: Hepatitis B and C Among Children and Young Adults in Rural Mongolia.
    J Viral Hepat. 2026;33:e70145.
    >> Share

  92. NAUSTDAL CN, Villadsen GE, Rex KF, Krarup HB, et al
    Viral Hepatitis B, C and Delta in Greenland: A National Cross-Sectional Study.
    J Viral Hepat. 2026;33:e70140.
    >> Share

  93. ELSABAAWY M, Naguib M, Magdy M, Shaban A, et al
    Refining Risk Stratification for Oesophageal Varices in HCV-Related Cirrhosis: A Comprehensive Analysis of the Albumin Platelet Product and Elastography Biomarkers.
    J Viral Hepat. 2026;33:e70146.
    >> Share

  94. GUERRA-VELOZ MF, Shah S, Emmanouil B, Olsen M, et al
    Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC.
    J Viral Hepat. 2026;33:e70148.
    >> Share

  95. YOU C, Diao Y, Tang J, Tang J, et al
    Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination.
    J Viral Hepat. 2026;33:e70150.
    >> Share

  96. KOGIAS D, Kouklakis G, Papadopoulos V
    Hepatitis E Infection in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70152.
    >> Share

  97. REN G, Jia K, Yi S, Yin S, et al
    Hepatic Steatosis Inhibits Hepatitis B Virus Replication by Promoting miR-122-5p-SOX4.
    J Viral Hepat. 2026;33:e70151.
    >> Share

  98. PAK K, Leng M, Nguyen J, Moussa K, et al
    Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus in Two Southern California Counties.
    J Viral Hepat. 2026;33:e70155.
    >> Share

  99. WANG CR, Zhu Q, Jing FC, Tang SX, et al
    Hepatitis B Virus Infection and the Risk of Cardiovascular Disease: Findings From the China Kadoorie Biobank.
    J Viral Hepat. 2026;33:e70157.
    >> Share

  100. MAKUZA JD, Law M, Puyat J, Ramji A, et al
    All-Cause Mortality in Persons With HIV-HBV Co-Infection Treated for HBV in Rwanda: A Population-Based Cohort Study.
    J Viral Hepat. 2026;33:e70158.
    >> Share

    February 2026
  101. KARICHASHVILI L, Shadaker S, Schumacher IT, Tsereteli M, et al
    Assessing the Seroprevalence of and Knowledge, Attitudes and Practices Related to Hepatitis B and Hepatitis C Among Dental Health Professionals in the Country of Georgia, 2023.
    J Viral Hepat. 2026;33:e70126.
    >> Share

  102. GERBAUD C, Debette-Gratien M, Guillouche P, Francois C, et al
    Managing Hepatitis C in Addiction Care Centers: Results of the French Real-Life NeoVie Study.
    J Viral Hepat. 2026;33:e70121.
    >> Share

  103. TANG W, Ma Y, Du L, Bai L, et al
    Association Between Indirect Bilirubin Percentage to Albumin Ratio and Outcome of Hepatitis B Related Acute on Chronic Liver Failure Treated With Artificial Liver Support System.
    J Viral Hepat. 2026;33:e70131.
    >> Share

  104. KATKURI SN, Vadhithala V, Kumar A, Verma S, et al
    Comments on "Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines".
    J Viral Hepat. 2026;33:e70132.
    >> Share

  105. KAMAL H, Jargalsaikhan G, Enkhtaivan S, Bruce D, et al
    Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023.
    J Viral Hepat. 2026;33:e70129.
    >> Share

  106. BARAKAT EMF, Kohla M, Tawheed A, Shousha HI, et al
    Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective Study.
    J Viral Hepat. 2026;33:e70127.
    >> Share

  107. YIN S, Hofmeister MG, Thompson ND, Teshale EH, et al
    Characteristics of Newly Reported Chronic Hepatitis C Cases Among Adults in the United States, 2016-2023: Insights From Population-Based Surveillance.
    J Viral Hepat. 2026;33:e70123.
    >> Share

  108. KIM HY, Lee HL, Nam H, Lee SK, et al
    Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.
    J Viral Hepat. 2026;33:e70134.
    >> Share

  109. GETIA V, Imnadze P, Adamia E, Tsereteli M, et al
    Identifying and Linking to Care and Treatment Persons With Hepatitis C Who Were Lost to Follow-Up, Georgia 2023-2024.
    J Viral Hepat. 2026;33:e70135.
    >> Share

  110. CAMPBELL C, Wang T, Barnes E, Matthews PC, et al
    Response to Comments on 'Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines'.
    J Viral Hepat. 2026;33:e70133.
    >> Share

  111. SUN J, Pourmarzi D
    Prevalence of Hepatitis B Among Migrants Living in High-Income Countries With Low/Intermediate HBV Prevalence-A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70106.
    >> Share

  112. NEJAT C
    The State of Hepatitis B in Florida in 2025: Current Challenges and Health Disparities.
    J Viral Hepat. 2026;33:e70136.
    >> Share

  113. HOFMEISTER MG, Yin S, Dokpesi P, Teshale EH, et al
    Epidemiology and Control of Widespread Community Hepatitis A Outbreaks in 37 U.S. States, 2016-2023.
    J Viral Hepat. 2026;33:e70137.
    >> Share

  114. DALY S, Reid L, Buchanan R, McCulloch P, et al
    Peer Interventions for Hepatitis C Testing and Treatment in OECD Countries: A Systematic Scoping Review.
    J Viral Hepat. 2026;33:e70130.
    >> Share

    January 2026
  115. FAN S, Imsirovic H, Garber G, Kelly E, et al
    Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades.
    J Viral Hepat. 2026;33:e70112.
    >> Share

  116. BIONDI MJ, Capraru CI, Harper B, Gill P, et al
    Pharmacist-Led Hepatitis C Diagnosis and Rapid Management-In Community (PHARM-C): Results From a Phase IV Nonblinded Randomised Controlled Trial.
    J Viral Hepat. 2026;33:e70109.
    >> Share

  117. MAZZILLI S, Aslam MK, Ahmed M, Wailly Y, et al
    Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022-June 2023.
    J Viral Hepat. 2026;33:e70103.
    >> Share

  118. LI X, Liao C, Gu Y, Lian Y, et al
    Immune Checkpoints Determine the NK/NKT and T Cell Immunity in Chronic Hepatitis B.
    J Viral Hepat. 2026;33:e70108.
    >> Share

  119. SIVAKUMAR H, Dhodapkar R, Chinnakali P, Philomenadin FS, et al
    Understanding the Serologic and Molecular Epidemiology of Hepatitis A Infection in Puducherry and Surrounding Regions of India.
    J Viral Hepat. 2026;33:e70104.
    >> Share

  120. TAYE B, Valery P, Ananta S, Kc S, et al
    Modelling Micro-Elimination: Third-Trimester Tenofovir Prophylaxis for Perinatal Transmission of Hepatitis B in the Remote Dolpa District of Nepal.
    J Viral Hepat. 2026;33:e70110.
    >> Share

  121. LI C, Lin L, Zhou P, Cai H, et al
    Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.
    J Viral Hepat. 2026;33:e70115.
    >> Share

  122. FEELEMYER J, Ban FK, Braithwaite RS, Bhattacharya D, et al
    Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response.
    J Viral Hepat. 2026;33:e70116.
    >> Share


  123. Correction to 'A Contactless Cure: Leveraging Telehealth to Improve Hepatitis C Treatment at a Safety-Net Hospital'.
    J Viral Hepat. 2026;33:e70117.
    >> Share

  124. MA H, Zheng J, Huang L, Qiu Z, et al
    Single-Arm Meta-Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights.
    J Viral Hepat. 2026;33:e70114.
    >> Share

  125. BAUMGARTEN T, Lehmann F, Senff T, Slanina H, et al
    Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up.
    J Viral Hepat. 2026;33:e70111.
    >> Share

  126. RAZAVI-SHEARER D, Gamkrelidze I, Hall S, Cohen C, et al
    The Current Burden of Hepatitis B in the United States: A State, Territorial, and County Modelling Analysis.
    J Viral Hepat. 2026;33:e70122.
    >> Share

  127. WONG RJ, Gish RG, Jacobson IM, Lim JK, et al
    Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States.
    J Viral Hepat. 2026;33:e70119.
    >> Share

  128. ZHOU J, Liu K, Boor PPC, Pan Q, et al
    The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages.
    J Viral Hepat. 2026;33:e70118.
    >> Share


  129. Correction to "Hepatitis B Patients' Adherence to Treatment in Relation to Knowledge, Attitudes, and Practices (KAP) in the West Bank, Palestine, 2022-2023".
    J Viral Hepat. 2026;33:e70120.
    >> Share

  130. CATER MG, Olasehinde T, Kim A, Choudhary E, et al
    Hepatitis B Vaccination Uptake and Associated Factors in the United States Before Implementing Universal Vaccination: A Nationally-Representative Study.
    J Viral Hepat. 2026;33:e70125.
    >> Share

  131. ATHALYE S, Khargekar N, Panale P, Shinde S, et al
    Molecular Insights Into the S Gene of Hepatitis B Virus: Analysis Among Household Contacts and Clinical Implications of Mutations.
    J Viral Hepat. 2026;33:e70124.
    >> Share

    December 2025
  132. DRYSDALE M, Gillespie IA, Christensen D, Davies J, et al
    Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study.
    J Viral Hepat. 2025;32:e70101.
    >> Share

  133. MARCELLIN F, di Beo V, Sogni P, Ramier C, et al
    Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France.
    J Viral Hepat. 2025;32:e70102.
    >> Share

  134. LAMPERTICO P, Anolli MP, Steppich K, Wedemeyer H, et al
    Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update.
    J Viral Hepat. 2025;32:e70056.
    >> Share

  135. EL-KASSAS M, Almattooq M, AlNaamani KM
    Targeted Screening for Hepatitis B: Insights From Hong Kong and Implications for Endemic Regions.
    J Viral Hepat. 2025;32:e70107.
    >> Share

    November 2025
  136. GONZALEZ CJ, Perez-Mejia CN, Hernandez N, Kapadia SN, et al
    Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties.
    J Viral Hepat. 2025;32:e70093.
    >> Share

  137. LAUREILLARD D, Binh NT, Vinh VH, Hong TT, et al
    High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.
    J Viral Hepat. 2025;32:e70090.
    >> Share

  138. GHANY MG, Ward JW, Baldwin Z, Jiao S, et al
    HCV Testing and Treatment of Adults in the United States: 2014 Through 2021-Data From Two National Commercial Testing Laboratories.
    J Viral Hepat. 2025;32:e70087.
    >> Share

  139. QURESHI H, Canchola JA, Hai G, Latif AQ, et al
    Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource-Limited Settings.
    J Viral Hepat. 2025;32:e70091.
    >> Share

  140. KOKER G
    Reassessing Cost-Effective Strategies for Hepatitis B Elimination: The Urgent Need for Action-Oriented Screening Models.
    J Viral Hepat. 2025;32:e70084.
    >> Share

  141. OLTMANNS C, Witte M, Wranke A, Deterding K, et al
    HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.
    J Viral Hepat. 2025;32:e70092.
    >> Share

  142. GRANTZ KH, Cummings DAT, Romero LM, Astemborski J, et al
    Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling Study.
    J Viral Hepat. 2025;32:e70096.
    >> Share

  143. HARDIE DR, Korsman SNJ, Valley-Omar Z, Petersen N, et al
    Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa.
    J Viral Hepat. 2025;32:e70095.
    >> Share

  144. XIE T, Su M, Cai M, Zhao T, et al
    Real-World Study for Mother-To-Child Transmission of Hepatitis B in Guangdong Province, 2021-2023.
    J Viral Hepat. 2025;32:e70094.
    >> Share

  145. BADIA L, Ciancio A, Distefano M, Izzi A, et al
    Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study.
    J Viral Hepat. 2025;32:e70097.
    >> Share

  146. CAMPBELL C, Wang T, Stockdale AJ, Todd S, et al
    Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.
    J Viral Hepat. 2025;32:e70098.
    >> Share

  147. HORWITZ R, Brener L, de Romas E, Wu KOE, et al
    Hepatitis B Knowledge, Attitudes and Mistrust in Western Medicine Among People of Filipino Ethnicity in Australia.
    J Viral Hepat. 2025;32:e70099.
    >> Share

  148. CONTHE A, Fueyo PR, Aguilera F, Iniesta C, et al
    Human Herpesvirus 6 in Acute Liver Failure: Leading Role, Supporting Actor or Innocent Bystander? A Case Series, Narrative Review and Management Algorithm Proposal.
    J Viral Hepat. 2025;32:e70100.
    >> Share

  149. KWON JH, Lee SW, Kim HY, Song DS, et al
    Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long-Term Clinical Outcomes.
    J Viral Hepat. 2025;32:e70083.
    >> Share

    October 2025
  150. HANDANAGIC S, Shadaker S, BaliashvilI D, Schumacher IT, et al
    Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co-Infection, Georgia, 2017-2023.
    J Viral Hepat. 2025;32:e70067.
    >> Share

  151. HUANG D, Zhu Z, Peng J, Zhang S, et al
    Global Trends and Health Inequalities in Acute Hepatitis E Burden: A Joinpoint Regression and Cross-Country Inequality Analysis, 1990-2021.
    J Viral Hepat. 2025;32:e70073.
    >> Share

  152. TORGERSEN J, Smookler D, Russell R, Gasior J, et al
    Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia.
    J Viral Hepat. 2025;32:e70066.
    >> Share

  153. KASSA GM, Lim AG, Tamiru MT, Alamneh TS, et al
    Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.
    J Viral Hepat. 2025;32:e70065.
    >> Share

  154. CONWAY A, Grebely J, Treloar C, Matthews S, et al
    Policymaker Perspectives on the Role of Health Systems in Sustainable Hepatitis C Point-Of-Care Testing in Australia.
    J Viral Hepat. 2025;32:e70080.
    >> Share

  155. AHAD M, Moussa D, Wallace J, Wade AJ, et al
    Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research.
    J Viral Hepat. 2025;32:e70069.
    >> Share

  156. MOHAREB AM, Ezaz G, Kim AY, Freedberg KA, et al
    Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.
    J Viral Hepat. 2025;32:e70079.
    >> Share

  157. ABU-DAYYEH I, Chemaitelly H, Al Tibi A, Ghunaim M, et al
    Hepatitis B Virus in Jordan: Prevalence, Incidence and Clearance From Cross-Sectional and Cohort Studies.
    J Viral Hepat. 2025;32:e70075.
    >> Share

  158. TAO X, Yu W, Yan Q, Han G, et al
    Age Modifies the Association Between HBV DNA Levels and Liver Dysfunction Risk During Pregnancy.
    J Viral Hepat. 2025;32:e70074.
    >> Share

  159. XIAO J, Zhang X, Mao X, Lai S, et al
    Efficacy and Safety of Velpatasvir Plus Sofosbuvir With or Without Ribavirin in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2025;32:e70078.
    >> Share

  160. YING X, Ng N, Reidy D, Azari J, et al
    Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70070.
    >> Share

  161. NATOUR RT, Haimi M, Hazan R, Saadi T, et al
    Reduced Predictive Performance of the FIB-4 Index in Chronic Hepatitis B Patients With Concurrent Metabolic Dysfunction-Associated Liver Disease.
    J Viral Hepat. 2025;32:e70071.
    >> Share

  162. LUONG CL, Ellett LK, Pratt N, Staff K, et al
    Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024.
    J Viral Hepat. 2025;32:e70082.
    >> Share

  163. BHATIA P, Mohd A, Katiyar H, Goel A, et al
    Longitudinal Profiles of Cytokines and Chemokines in Self-Limiting Hepatitis E.
    J Viral Hepat. 2025;32:e70088.
    >> Share

  164. YAN L, Yuan M, Su M, Cui K, et al
    U-Shaped Relationship Between CT-Measured Liver-To-Spleen Volume Ratio and Mortality in HBV-ACLF Patients.
    J Viral Hepat. 2025;32:e70076.
    >> Share

  165. BUGSSA G, Teklehaymanot T, Medhin G, Nayagam S, et al
    Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray Region, Northern Ethiopia.
    J Viral Hepat. 2025;32:e70077.
    >> Share

  166. VOJT G, Bonnet P, Scott J, Hathorn E, et al
    Peer-Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and Treatment Among Unhoused People.
    J Viral Hepat. 2025;32:e70085.
    >> Share

  167. ZHANG L, Ji H, Pang S, Yan Y, et al
    Identifying Adherence Trajectories in Chronic Hepatitis B: A Cluster-Based Approach to Long-Term Treatment Management.
    J Viral Hepat. 2025;32:e70068.
    >> Share

  168. CHAU A, Li J, Jun DW, Hsu YC, et al
    Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.
    J Viral Hepat. 2025;32:e70081.
    >> Share

  169. WONG RJ, Yang Z, Lim J, Jou JH, et al
    High Prevalence of Cirrhosis or Hepatocellular Carcinoma at Hepatitis Delta Infection Diagnosis Reflects Alarming Delays in Testing.
    J Viral Hepat. 2025;32:e70086.
    >> Share

  170. SALAMANCA BV, Johannessen A, Dalgard O, Whittaker R, et al
    Linkage to Care, Retention in Care and Treatment Uptake Among Patients Diagnosed With Chronic Hepatitis B in Norway, 2008-2022.
    J Viral Hepat. 2025;32:e70089.
    >> Share

    September 2025
  171. WANG M, Wang Y, Yang Z, Yang C, et al
    Clinical Observational Study on HBV Reactivation After Direct-Acting Antiviral Therapy in HCV/HBV Coinfected Patients in Guizhou, China.
    J Viral Hepat. 2025;32:e70061.
    >> Share

  172. BOUDOVA S, Iyer NS, Tholey DM, Fenkel JM, et al
    The Effect of HCV on Methadone Dose During Pregnancy.
    J Viral Hepat. 2025;32:e70060.
    >> Share

  173. KAWAMATSU S, Rai KK, Gielen V, Patel A, et al
    Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study.
    J Viral Hepat. 2025;32:e70062.
    >> Share

  174. GREEN F, Simmons R, Leeman D, Desai M, et al
    Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis C Viruses.
    J Viral Hepat. 2025;32:e70064.
    >> Share

  175. REMY AJ, Bellon S, Smadhi R, Bottlaender J, et al
    HCV Screening Before Endoscopy in Hepatogastroenterology Outpatient Clinic: The Depist C Endo Study.
    J Viral Hepat. 2025;32:e70063.
    >> Share

    August 2025
  176. LI Y, Li Z, Chen R, Jia C, et al
    Global, Regional and National Burden of Chronic Hepatitis C, 1990-2021: A Systematic Analysis for the GBD Study 2021.
    J Viral Hepat. 2025;32:e70053.
    >> Share

  177. HUI VW, Yang Z, Yip TC, Cheung R, et al
    Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related Cirrhosis.
    J Viral Hepat. 2025;32:e70049.
    >> Share

  178. HEATH K, Guzman R, Elsum I, Wade AJ, et al
    Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial.
    J Viral Hepat. 2025;32:e70043.
    >> Share

  179. GAO Y, Yang P, Guan Y, Liu P, et al
    M1-Like Macrophage May Contribute to the Inflammation and Fibrosis Process of Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70052.
    >> Share

  180. SONGTANIN B, Flores J, Barba R, Saba J, et al
    Occult Hepatitis C Virus Infection: A Narrative Review.
    J Viral Hepat. 2025;32:e70051.
    >> Share

  181. ANDERSON S, Gielen V, Coutinho AD, Clark L, et al
    Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States.
    J Viral Hepat. 2025;32:e70055.
    >> Share

  182. CONWAY B, Yi S, Truong D
    CHIME: Sofosbuvir/Velpatasvir (S/V) for the Treatment of HCV Infection Among Vulnerable Inner-City Residents.
    J Viral Hepat. 2025;32:e70057.
    >> Share

  183. HE Q, Dong J, Huang L, Gao Y, et al
    Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003-2021, China.
    J Viral Hepat. 2025;32:e70054.
    >> Share

  184. GENOWSKA A, Dobrowolska K, Zarebska-Michaluk D, Tyszko P, et al
    Trends and Socio-Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12-Year Nationwide Analysis.
    J Viral Hepat. 2025;32:e70059.
    >> Share

    July 2025
  185. ELBAZ T, Al-Naamani K, Abosheaishaa H, Alswat K, et al
    Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in Egypt.
    J Viral Hepat. 2025;32:e70032.
    >> Share

  186. MAUNG ST, Chaiteerakij R
    Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70040.
    >> Share

  187. FREELAND C, Plunkett Q, Sirapu S, Cohen C, et al
    A Person-Centered Hepatitis B Approach Using the COM-B Model to Understand Barriers and Facilitators of Hepatitis B Testing, Management and Treatment.
    J Viral Hepat. 2025;32:e70041.
    >> Share

  188. RAMIER C, Carrat F, Beo VD, Parlati L, et al
    Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER).
    J Viral Hepat. 2025;32:e70033.
    >> Share

  189. SHIHA G, Helmy A, Mikhail N, Hassan A, et al
    Long Term Clinical Outcomes in Chronic Hepatitis C Patients Who Achieved SVR Following DAAs: A Decade Long Prospective Study.
    J Viral Hepat. 2025;32:e70044.
    >> Share

  190. ADEBAJO A, Qiao S, Esu I, Olatosi B, et al
    The Efficacy and Sustainability of an Implementation Intervention (FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center in the Deep South: A Longitudinal Study Based on Electronic Medical Records.
    J Viral Hepat. 2025;32:e70045.
    >> Share

  191. YARDENI D, Cividalli O, Itkowitz B, Lipnizkiy I, et al
    Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV Detection Rate in Israel.
    J Viral Hepat. 2025;32:e70046.
    >> Share

  192. RAYNER D, McCullough F, McQue K, Jones K, et al
    Prospective Evaluation of Blood Borne Virus Testing in Custody Suites in North-East England.
    J Viral Hepat. 2025;32:e70042.
    >> Share

  193. HU X, Wan S, Yan H, Tang M, et al
    Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection.
    J Viral Hepat. 2025;32:e70047.
    >> Share

  194. TAKAKI S, Ohya K, Mori N, Ochi H, et al
    Hepatitis C Patients Over the Age of 75 Should Be Treated With Direct-Acting Antivirals, as Their Prognosis With Treatment Is Similar to That of Uninfected Healthy Individuals of the Same Age.
    J Viral Hepat. 2025;32:e70048.
    >> Share

    June 2025
  195. MARLOWE EM, Swanson BE, Realegeno SE, Meyer WA 3rd, et al
    Epidemiological Burden of Hepatitis Delta Virus in the United States.
    J Viral Hepat. 2025;32:e70029.
    >> Share

  196. LI S, Dong W, Yu Y, Yang Z, et al
    A Government-Led, Patient-Centric Strategy to Re-Engage Diagnosed but Untreated Hepatitis C Patients in Yunnan Province, China.
    J Viral Hepat. 2025;32:e70028.
    >> Share

  197. XU C, Yin DH, Han JH, Gao YN, et al
    Efficacy of Traditional Chinese Medicine External Therapies in Treating Insomnia in Patients With Chronic Hepatitis B: Systematic Review and Meta-Analysis.
    J Viral Hepat. 2025;32:e70030.
    >> Share

  198. SANDMANN L, Windzio L, Bremer B, Falak S, et al
    Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection Limits.
    J Viral Hepat. 2025;32:e70036.
    >> Share

  199. HIRODE G, Kilany M, Pi S, Kim A, et al
    Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation.
    J Viral Hepat. 2025;32:e70031.
    >> Share

  200. IACOB S, Chitul M, Stan D, Gheorghe D, et al
    Identifying Risk Factors for Hepatocellular Carcinoma in Patients With Delta Hepatitis: A Prognostic Study.
    J Viral Hepat. 2025;32:e70034.
    >> Share

  201. PENG Y, Song Y, Liu X, Du X, et al
    Host Factor SRSF7 Promotes HBV Replication Through Binding to and Stabilising Viral pgRNA.
    J Viral Hepat. 2025;32:e70024.
    >> Share

  202. SI NAFA SA, Benali S, Penaranda G, Deuffic-Burban S, et al
    Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO Study.
    J Viral Hepat. 2025;32:e70038.
    >> Share

  203. MENDIZABAL M, Sabate CD, Gonzalez Ballerga E, Gruz F, et al
    Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines.
    J Viral Hepat. 2025;32:e70035.
    >> Share

    May 2025
  204. WANG X, Yan X, He B, Li B, et al
    Global Burden and Trends of Acute Hepatitis C From 1990 to 2021: An Analysis Based on the 2021 Global Burden of Disease Study.
    J Viral Hepat. 2025;32:e70026.
    >> Share

  205. WONG NS, Chan DP, Wong GL, Lee SS, et al
    Cost-Effectiveness of Universal Screen-and-Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High-Endemicity City.
    J Viral Hepat. 2025;32:e70027.
    >> Share

    April 2025
  206. INOUE J, Minami S, Abe K, Kida M, et al
    Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.
    J Viral Hepat. 2025;32:e70021.
    >> Share

  207. VAITTINADA AYAR P, Abdelkader J, Gay M, Allali R, et al
    Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department.
    J Viral Hepat. 2025;32:e70018.
    >> Share

  208. AHMED S, Nadir MA, Farooqi HA, Ashraf H, et al
    Enhancing Hepatitis C Management: Mortality Trends and Disparities in the US by Sex, Age Group, Race/Ethnicity and Region (1999-2020).
    J Viral Hepat. 2025;32:e70011.
    >> Share

  209. JIA Y, Qi X, Yu X, Dong M, et al
    Accuracy of International Guidelines in Identifying Normal Liver Histology in Chinese Patients With HBeAg-Positive Chronic HBV Infection.
    J Viral Hepat. 2025;32:e14024.
    >> Share

  210. RONG X, Yang G, Xu Y, Chen H, et al
    Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First-Time HBV-Related Decompensated Cirrhosis.
    J Viral Hepat. 2025;32:e14029.
    >> Share

  211. XUE K, Wen L, Ji X, Yan X, et al
    Impact of HBV Infection in Couples on In Vitro Fertilisation-Embryo Transfer Outcomes and Clinical Characteristics of Newborns: A Retrospective Study Based on 3900 Infertile Couples.
    J Viral Hepat. 2025;32:e70015.
    >> Share

  212. AN W, Li M, Luo J, Yu Z, et al
    Prognosis of Acute HEV Infection in Patients With Liver Cirrhosis: A Retrospective Study of 628 Chinese Patients.
    J Viral Hepat. 2025;32:e14018.
    >> Share

  213. SUN J, Kelly M, Tsheten T, Pourmarzi D, et al
    Prevalence of Hepatitis C Among Migrants: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2025;32:e70025.
    >> Share

  214. HARDTKE S, Yurdaydin C, Caruntu FA, Curescu MG, et al
    Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection.
    J Viral Hepat. 2025;32:e70022.
    >> Share

  215. LIANG H, Zheng X, Liu Y, Mao Q, et al
    Effects of Different Antiviral Treatments on Liver Inflammation and Fibrosis in Patients With Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70019.
    >> Share

  216. HUI RW, Wong DK, Mak LY, Fung J, et al
    Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA Detection.
    J Viral Hepat. 2025;32:e70023.
    >> Share

  217. POWELL AA, Costella A, Roche R, Leeman D, et al
    Sensitivity Analysis of Hepatitis B and C Mortality in England Using Data Linkage: Meeting the WHO Elimination Threshold for Mortality.
    J Viral Hepat. 2025;32:e70016.
    >> Share

    March 2025
  218. BARRE T, Ramier C, Ory K, Saidi T, et al
    Liver Enzyme Elevation After Hepatitis C Virus Cure: Is There a Sex Effect? (ANRS CO13 HEPAVIH Cohort).
    J Viral Hepat. 2025;32:e70007.
    >> Share

  219. EILARD A, Ringlander J, Andersson ME, Nilsson S, et al
    Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma.
    J Viral Hepat. 2025;32:e70008.
    >> Share

  220. PARK C, Hwang G, Choi WM, Han JE, et al
    Baseline Alpha-Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study.
    J Viral Hepat. 2025;32:e70006.
    >> Share

  221. KOGIAS D, Gavriilidis E, Antoniadou C, Skeva A, et al
    Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab.
    J Viral Hepat. 2025;32:e70005.
    >> Share

  222. CHELOUAH S, Nna H, Angijiro P, Thomas F, et al
    Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir.
    J Viral Hepat. 2025;32:e70014.
    >> Share

  223. WANG H, Xu C, Yao R, Zhang W, et al
    Single-Cell Transcriptome Identifies a Proinflammatory B-Cell Subset in Hepatitis B Virus Associated Acute-on-Chronic Liver Failure.
    J Viral Hepat. 2025;32:e70012.
    >> Share

  224. ZOU H, Zhu L, Cao L, Suo S, et al
    Vertical Transmission in Mothers Taking TAF With Exceptionally High Viral Load.
    J Viral Hepat. 2025;32:e70000.
    >> Share

  225. JUON HS, Yang D, Fang CX, Hann HW, et al
    Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70010.
    >> Share

  226. ZHANG Y, Jin D, Zhu H, Lin M, et al
    Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B.
    J Viral Hepat. 2025;32:e70017.
    >> Share

    February 2025
  227. WANG H, Wang J, Zhang S, Zhang S, et al
    Clinical Features and Transition of Acute Hepatitis B Virus Infection.
    J Viral Hepat. 2025;32:e14048.
    >> Share

  228. ZHANG Z, Wang J, Zhu L, Li Y, et al
    Optimization of the Use of APRI and FIB-4 for Ruling Out Liver Cirrhosis in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
    J Viral Hepat. 2025;32:e14057.
    >> Share

  229. EMERY H, Evans C, Jack K, Martello E, et al
    A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.
    J Viral Hepat. 2025;32:e14049.
    >> Share

  230. MUTIMER D, Brown M, Logan J, Kelgeri C, et al
    Patient Source of Referral Is a Key Determinant of Subsequent Retention in Care for Young Chronic Hepatitis B Patients.
    J Viral Hepat. 2025;32:e14059.
    >> Share

  231. PERERA H, Imsirovic H, Macphail G, Webster D, et al
    Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC Analysis.
    J Viral Hepat. 2025;32:e14058.
    >> Share

  232. SINGAL AG, Reddy KR, Colombo M, Morris HL, et al
    DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.
    J Viral Hepat. 2025;32:e14056.
    >> Share

  233. HILTON B, De Angelis D, Mitchell H, Harris R, et al
    Heterogeneity in Risk and Implications for Hepatitis C Reinfection in People Who Inject Drugs in England.
    J Viral Hepat. 2025;32:e14052.
    >> Share

  234. VOELLER AS, Johannessen A, Abebe ZZ, Adugna W, et al
    The Disease and Economic Burden of HBV and HCV in Ethiopia.
    J Viral Hepat. 2025;32:e14053.
    >> Share

  235. GU Y, Gu L, Chen L, Li J, et al
    Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T-Cells Combined Antiviral Drugs in Treatment Naive CHB Patients-A Multi-Centre Phase II Study.
    J Viral Hepat. 2025;32:e14045.
    >> Share

  236. FURQUIM D'ALMEIDA A, Ho E, Govaerts L, Michielsen P, et al
    Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up Study.
    J Viral Hepat. 2025;32:1-15.
    >> Share

  237. ONG E, Xia T, Laing R, Richmond JA, et al
    Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional Survey.
    J Viral Hepat. 2025;32:e70001.
    >> Share

  238. RAMRAKHIANI H, Le MH, Kam L, Nguyen B, et al
    Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2025;32:e70003.
    >> Share

  239. UKAGEBU CJ, Alao JO, Bamigboye FO, Ukaegbu JC, et al
    Evaluating Hepatitis B Screening During Pregnancy: A Study on Diagnostic Accuracy and Infection Control in Nigeria.
    J Viral Hepat. 2025;32:e70002.
    >> Share

  240. MENNINI FS, Sciattella P, Simonelli C, Marcellusi A, et al
    Long-Term Effects of Direct-Acting Antivirals on Hepatitis C: Trends in Liver Disease-Related Hospitalisations in Italy.
    J Viral Hepat. 2025;32:e14061.
    >> Share

  241. ELGRETLI W, Shengir M, Sasson S, Ramanakumar AV, et al
    Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors.
    J Viral Hepat. 2025;32:e70004.
    >> Share

  242. TAN X, Xun L, Yin Q, Chen C, et al
    Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma.
    J Viral Hepat. 2025;32:e14044.
    >> Share

    January 2025
  243. QURESHI M
    A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C in Pakistan.
    J Viral Hepat. 2025;32:e14050.
    >> Share

  244. SAID SS, Shadaker S, McMahon BJ, Armstrong PA, et al
    Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project Following 2015 WHO Treatment Guidelines, 2017-2021.
    J Viral Hepat. 2025;32:e14051.
    >> Share

  245. WANG B, Wang X, Xiao L, Xian J, et al
    Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti-HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection.
    J Viral Hepat. 2025;32:e14046.
    >> Share

  246. CAUSSE X, Potier P, Valery A, Labadie H, et al
    Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.
    J Viral Hepat. 2025;32:e14041.
    >> Share

  247. LI M, Hunt B, Balani B, Ogedegbe C, et al
    A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive Patients for Hepatitis D.
    J Viral Hepat. 2025;32:e14043.
    >> Share

  248. TSAI YN, Lo JC, Tseng CH, Hsieh SC, et al
    Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy.
    J Viral Hepat. 2025;32:1-8.
    >> Share

  249. SAWALMEH A, Johansson EW, Kostas D, Hjaijeh D, et al
    Hepatitis B Patients' Adherence to Treatment in Relation to Knowledge, Attitudes, and Practices (KAP) in the West Bank, Palestine, 2022-2023.
    J Viral Hepat. 2025;32:e14055.
    >> Share

  250. POOROLAJAL J, Shadi Y, Heshmati B
    Interaction Between Hepatitis B, Hepatitis C and Alcohol in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2025;32:e14042.
    >> Share

  251. PARLAR YE, Gulnar MO, Kirmizigul B, Gencdal G, et al
    The Course of COVID-19 Infection in Patients With Chronic Hepatitis Delta.
    J Viral Hepat. 2025;32:e14054.
    >> Share

    December 2024
  252. BERTOLETTI A
    The immune response in chronic HBV infection.
    J Viral Hepat. 2024;31 Suppl 2:43-55.
    >> Share

  253. VO-QUANG E, Lemoine M
    Global elimination of HBV: Is it really achievable?
    J Viral Hepat. 2024;31 Suppl 2.
    >> Share

  254. LIM YS
    Treatment decisions based on HBV DNA.
    J Viral Hepat. 2024;31 Suppl 2:36-42.
    >> Share

    November 2024
  255. PARK Y, Heo J, Kang D, Gwak GY, et al
    Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk in Offspring: A National Cohort Study.
    J Viral Hepat. 2024 Nov 26. doi: 10.1111/jvh.14036.
    >> Share

  256. ROSECRANS A, Harris R, Clair AS, Rice M, et al
    Challenges and Opportunities for Treating Hepatitis C Amongst People Who Use Drugs: Experience of an Integrated Mobile Clinic in Baltimore City.
    J Viral Hepat. 2024 Nov 26. doi: 10.1111/jvh.14038.
    >> Share

  257. YEW KC, Sim ASY, Hawkins R, Acharyya S, et al
    Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort.
    J Viral Hepat. 2024 Nov 22. doi: 10.1111/jvh.14039.
    >> Share

  258. KASSA GM, Weldemariam AG, Abrahim SA, French CE, et al
    Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey.
    J Viral Hepat. 2024 Nov 21. doi: 10.1111/jvh.14037.
    >> Share

  259. FURL R, Scarsi KK, Sayles H, Anderson M, et al
    Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.
    J Viral Hepat. 2024 Nov 15. doi: 10.1111/jvh.14031.
    >> Share

  260. ANDANI A, Mellou K, Dewda P, Eeuwijk J, et al
    Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years.
    J Viral Hepat. 2024 Nov 11. doi: 10.1111/jvh.14030.
    >> Share

  261. WONG GL
    Updated Guidelines for the Prevention and Management of Chronic Hepatitis B-World Health Organization 2024 Compared With China 2022 HBV Guidelines.
    J Viral Hepat. 2024 Nov 6. doi: 10.1111/jvh.14032.
    >> Share

  262. DIRKS M, Hennemann AK, Grosse GM, Beer A, et al
    Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment.
    J Viral Hepat. 2024 Nov 6. doi: 10.1111/jvh.14033.
    >> Share

  263. DAS S, Sood V, Rastogi A, Agarwal N, et al
    Clinico-Pathological Spectrum of Hepatitis A Virus-Induced Autoimmune-Like Hepatitis in Children.
    J Viral Hepat. 2024 Nov 1. doi: 10.1111/jvh.14028.
    >> Share

    October 2024
  264. ETOORI D, Cococcia S, Srivastava A, Flanagan S, et al
    The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case-Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary Care.
    J Viral Hepat. 2024 Oct 24. doi: 10.1111/jvh.14027.
    >> Share

  265. ALI I, Muhammad S, Naqvi SSZH, Wei L, et al
    Hepatitis B Virus-Associated Liver Carcinoma: The Role of Iron Metabolism and Its Modulation.
    J Viral Hepat. 2024 Oct 24. doi: 10.1111/jvh.14016.
    >> Share

  266. GINNANE JF, Scott N, Radley A, Dillon JF, et al
    Cost-Effectiveness of Treating Hepatitis C in Clients on Opioid Agonist Therapy in Community Pharmacies Compared to Primary Healthcare in Australia.
    J Viral Hepat. 2024 Oct 23. doi: 10.1111/jvh.14015.
    >> Share

  267. MARTIN MT, Hietpas AR, Novak JL, Deming P, et al
    A National Survey of Pharmacist Involvement in Hepatitis C Virus Management in the United States.
    J Viral Hepat. 2024 Oct 22. doi: 10.1111/jvh.14014.
    >> Share

  268. YI S, Wiesmann C, Truong D, Sharma S, et al
    Community Pop-Up Clinic: Cascade of Care and HCV Treatment of Vancouver's Inner-City PWID Populations.
    J Viral Hepat. 2024 Oct 19. doi: 10.1111/jvh.14023.
    >> Share

  269. OHLENDORF V, Wubbolding M, Honer Zu Siederdissen C, Bremer B, et al
    Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients.
    J Viral Hepat. 2024 Oct 19. doi: 10.1111/jvh.14026.
    >> Share

  270. SIMMONS R, Harris R, Lim AG, Leeman D, et al
    Estimating Prevalence and Number of People With Chronic Hepatitis B: A Multiplier Method Based on Public Health Surveillance Data in UK (2015-2021).
    J Viral Hepat. 2024 Oct 16. doi: 10.1111/jvh.14019.
    >> Share

  271. IWADARE T, Kimura T, Sugiura A, Okumura T, et al
    Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.
    J Viral Hepat. 2024 Oct 15. doi: 10.1111/jvh.14025.
    >> Share

  272. BALIASHVILI D, Merabishvili T, Tskhomelidze I, Tsereteli M, et al
    Evaluation of Hepatitis C Virus Transmission Through Endoscopy Procedures in the Country of Georgia.
    J Viral Hepat. 2024 Oct 14. doi: 10.1111/jvh.14022.
    >> Share

  273. ZAKALASHVILI M, Surguladze S, Baliashvili D, Zarkua J, et al
    Evaluation of Knowledge, Attitudes and Practices for Hepatitis B Virus Infection Among Primary Healthcare Physicians in Georgia.
    J Viral Hepat. 2024 Oct 10. doi: 10.1111/jvh.14011.
    >> Share

  274. BUTT AA, Yan P, Iwnetu R, Malik AA, et al
    Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis B-Infected Veterans in the USA.
    J Viral Hepat. 2024 Oct 9. doi: 10.1111/jvh.14021.
    >> Share

  275. CHEN Y, Zhang X, Yan X, Wang L, et al
    A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China.
    J Viral Hepat. 2024 Oct 9. doi: 10.1111/jvh.14020.
    >> Share

  276. LU Z, Sun YM, Chen S, Meng T, et al
    Multiple Low-Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy.
    J Viral Hepat. 2024 Oct 7. doi: 10.1111/jvh.14012.
    >> Share

  277. PHAW NA, Rayner D, Johnson A, Thompson C, et al
    Harm Minimisation and Other Preventative Measures Must Improve to Reduce Transmission of Hepatitis C in Prisons.
    J Viral Hepat. 2024 Oct 7. doi: 10.1111/jvh.14017.
    >> Share

  278. BULDUKOGLU OC, Ocal S, Cekin AH
    Disparities in the Detection, Diagnosing and Treatment of Hepatitis B Among Females.
    J Viral Hepat. 2024 Oct 5. doi: 10.1111/jvh.14013.
    >> Share

  279. WAN Y, Yin S, Wu C
    Reply: Regarding the Predictive Role of CXCL16 in Liver Inflammation in Chronic Hepatitis B Patients.
    J Viral Hepat. 2024 Oct 5. doi: 10.1111/jvh.13996.
    >> Share

  280. ZHANG HL, Nemeth H, Woodhouse EW, Davenport CA, et al
    Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure.
    J Viral Hepat. 2024 Oct 3. doi: 10.1111/jvh.14009.
    >> Share

  281. PATEL P, Wells MT, Wethington E, Shapiro M, et al
    United States Provider Experiences With Telemedicine for Hepatitis C Treatment: A Nationwide Survey.
    J Viral Hepat. 2024 Oct 1. doi: 10.1111/jvh.14010.
    >> Share

  282. MAKUZA JD, Wong S, Morrow RL, Binka M, et al
    Impact of COVID-19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study.
    J Viral Hepat. 2024;31:592-600.
    >> Share

    September 2024
  283. TULENKO SE, Ngimbi P, Mwandagalirwa K, Tabala M, et al
    Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic Republic of Congo: A Randomised, Controlled Trial.
    J Viral Hepat. 2024 Sep 24. doi: 10.1111/jvh.14003.
    >> Share

  284. ZOVICH B, Patel P, Tu T, Wang S, et al
    Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and Unmet Needs Along the Care Cascade.
    J Viral Hepat. 2024 Sep 17. doi: 10.1111/jvh.14005.
    >> Share

  285. SONG Y, Chen H, Li J, Zhong F, et al
    Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection.
    J Viral Hepat. 2024 Sep 16. doi: 10.1111/jvh.14008.
    >> Share

  286. LIANG LY, Yip TC, Lai JC, Lam AS, et al
    Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment.
    J Viral Hepat. 2024 Sep 10. doi: 10.1111/jvh.14004.
    >> Share

  287. BARRE T, Parlati L, Bourliere M, Ramier C, et al
    Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather).
    J Viral Hepat. 2024 Sep 10. doi: 10.1111/jvh.14006.
    >> Share

  288. KWOK TY, Hui RW, Mao X, Ling GS, et al
    Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity.
    J Viral Hepat. 2024 Sep 9. doi: 10.1111/jvh.14007.
    >> Share

  289. GRANTZ KH, Cepeda J, Astemborski J, Kirk GD, et al
    Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.
    J Viral Hepat. 2024 Sep 5. doi: 10.1111/jvh.13999.
    >> Share

  290. HOFMEISTER MG, Ly KN, Yin S, Spradling PR, et al
    Evolving Characteristics of Decedents With Hepatitis A Listed as a Cause of Death, United States, 2011-2021.
    J Viral Hepat. 2024 Sep 3. doi: 10.1111/jvh.14002.
    >> Share

    August 2024
  291. PAK K, Ibrahim B, Saab S
    Safety of Tenofovir Disoproxil Fumarate Among Breastfeeding Infants of Patients With Chronic Hepatitis B: A Systematic Review.
    J Viral Hepat. 2024 Aug 29. doi: 10.1111/jvh.14001.
    >> Share

  292. MAHAJAN A, Kharawala S, Desai S, Kendrick S, et al
    Association of Hepatitis B Surface Antigen Levels With Long-Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review.
    J Viral Hepat. 2024 Aug 16. doi: 10.1111/jvh.13988.
    >> Share

  293. SACHAR Y, Congly SE, Burak KW, Manko A, et al
    Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B-Related Hepatocellular Carcinoma.
    J Viral Hepat. 2024 Aug 16. doi: 10.1111/jvh.13989.
    >> Share

  294. WEI B, Li H, Cheng M, Yang Y, et al
    NLRP3 Inflammasome Activation Mediates Hepatitis E Virus-Induced Neuroinflammation.
    J Viral Hepat. 2024 Aug 13. doi: 10.1111/jvh.13998.
    >> Share

  295. THORNTON KA, Deming PD, Archer GRD, Ceniceros JA, et al
    Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System: Using the ECHO Model for Provider and Prison Peer Education.
    J Viral Hepat. 2024 Aug 13. doi: 10.1111/jvh.13997.
    >> Share

  296. IMSIROVIC H, Macphail G, Conway B, Fraser C, et al
    Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis.
    J Viral Hepat. 2024 Aug 12. doi: 10.1111/jvh.13995.
    >> Share

  297. WASUWANICH P, Wen TS, Egerman RS, Karnsakul W, et al
    Epidemiology and Outcomes of Hepatitis E Virus-Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998-2020.
    J Viral Hepat. 2024 Aug 11. doi: 10.1111/jvh.13994.
    >> Share

  298. CAVIGLIA GP, Casalone E, Olivero A, Birolo G, et al
    MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment.
    J Viral Hepat. 2024 Aug 11. doi: 10.1111/jvh.14000.
    >> Share

  299. EL EKIABY M, Tanaka J, van Drimmelen H, Allain JP, et al
    Infectivity of Hepatitis B Virus Surface Antigen-Positive Plasma With Undetectable HBV-DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?
    J Viral Hepat. 2024 Aug 10. doi: 10.1111/jvh.13990.
    >> Share

  300. RUPASINGHE D, Choi JY, Kumarasamy N, Pujari S, et al
    Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific Region.
    J Viral Hepat. 2024 Aug 8. doi: 10.1111/jvh.13993.
    >> Share

  301. PATEL NH, Lucko A, Vachon A, Doucette KE, et al
    Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease.
    J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13979.
    >> Share

  302. HAMA SA, Sirwan R, Abubakr M, Ahmed GS, et al
    Clinical Prevalence of Hepatitis D Virus Among Hepatitis B Patients in Sulaymaniyah Governorate, Northern Iraq.
    J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13987.
    >> Share

  303. FLISIAK R, Zarebska-Michaluk D, Janczewska E, Parfieniuk-Kowerda A, et al
    Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment.
    J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13991.
    >> Share

  304. WONG RJ, Liao M, Chen Y, Kwan M, et al
    Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B.
    J Viral Hepat. 2024 Aug 5. doi: 10.1111/jvh.13992.
    >> Share

    July 2024
  305. YENDEWA GA, Salata RA, Olasehinde T, Mulindwa F, et al
    Self-reported hepatitis B testing among noninstitutionalized adults in the United States before the implementation of universal screening, 2013-2017: A nationwide population-based study.
    J Viral Hepat. 2024 Jul 30. doi: 10.1111/jvh.13985.
    >> Share

  306. STASI C, Pacifici M, Puglia M, Voller F, et al
    Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?
    J Viral Hepat. 2024 Jul 29. doi: 10.1111/jvh.13978.
    >> Share

  307. TRAMONTI FANTOZZI MP, Ceccarelli L, Petri D, De Vita E, et al
    Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic.
    J Viral Hepat. 2024 Jul 27. doi: 10.1111/jvh.13983.
    >> Share

  308. ALAMNEH TS, Walker JG, Lim AG, Alam E, et al
    Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019.
    J Viral Hepat. 2024 Jul 26. doi: 10.1111/jvh.13986.
    >> Share

  309. CHEN B, Iqbal U, Desai SK, Gries J, et al
    The role of treatment of hepatitis C with direct-acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta-analysis.
    J Viral Hepat. 2024 Jul 24. doi: 10.1111/jvh.13984.
    >> Share

  310. HUTTON DW, Toy M, Yang D, Zhang H, et al
    Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States.
    J Viral Hepat. 2024 Jul 22. doi: 10.1111/jvh.13982.
    >> Share

  311. BEYDOUN HA, Tsai J
    Screening rates for hepatitis B and C among low-income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study.
    J Viral Hepat. 2024 Jul 10. doi: 10.1111/jvh.13981.
    >> Share

  312. HUANG D, Lai H, Zhu Z, Yu H, et al
    Inverse relationship between HBV DNA levels and liver histopathological changes in immune-tolerant CHB patients.
    J Viral Hepat. 2024;31:363-371.
    >> Share

    June 2024
  313. ZHANG J, Zhang Y
    Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients.
    J Viral Hepat. 2024 Jun 10. doi: 10.1111/jvh.13976.
    >> Share

  314. LI T, Chen Y, Zhang Y, Wu S, et al
    Elevated hepatitis B virus RNA levels in HBeAg-positive patients with low-level viraemia or previous low-level viraemia.
    J Viral Hepat. 2024 Jun 10. doi: 10.1111/jvh.13957.
    >> Share

  315. COSTE M, Diouf A, Ndong C, Diouf A, et al
    Investigating linkage to care following community-based screening for hepatitis B virus in rural Senegal: A mixed methods study.
    J Viral Hepat. 2024 Jun 5. doi: 10.1111/jvh.13977.
    >> Share

  316. CLIPMAN SJ, Mehta SH, Mohapatra S, Srikrishnan AK, et al
    Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.
    J Viral Hepat. 2024 Jun 4. doi: 10.1111/jvh.13960.
    >> Share

  317. MOUSAVI S, Alavi M, Delavari A, Poustchi H, et al
    Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies.
    J Viral Hepat. 2024 Jun 3. doi: 10.1111/jvh.13975.
    >> Share

    May 2024
  318. KHAN N, Kakakhel S, Malik A, Nigar K, et al
    Genetic substructure and host-specific natural selection trend across vaccine-candidate ORF-2 capsid protein of hepatitis-E virus.
    J Viral Hepat. 2024 May 28. doi: 10.1111/jvh.13959.
    >> Share

  319. DOWNS LO, Kabagambe K, Williams S, Waddilove E, et al
    Peer support for people living with hepatitis B virus-A foundation for treatment expansion.
    J Viral Hepat. 2024 May 26. doi: 10.1111/jvh.13952.
    >> Share

  320. SHAYAN NA, Rahimi A, Stranges S, Thind A, et al
    Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan: A case-control study.
    J Viral Hepat. 2024 May 24. doi: 10.1111/jvh.13961.
    >> Share

  321. KOCHAKSARAEI GS, Yang F, Seow CH, Barkema HW, et al
    Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population-based study.
    J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13954.
    >> Share

  322. GU Q, Yin S, Tong X, Rui F, et al
    Current research insights into the role of CTLA-4 in hepatitis B virus (HBV) infection.
    J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13958.
    >> Share

  323. QURESHI H, Mahmood H, Nasir Z, Siddique S, et al
    A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022.
    J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13953.
    >> Share

  324. LE GUILLOU-GUILLEMETTE H, Pivert A, ElBara A, Vall M, et al
    Prevalence, clinical and virological characteristics and short-term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania.
    J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13950.
    >> Share

  325. IRVIN R, Landry G, Jones MR, James A, et al
    High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    J Viral Hepat. 2024 May 17. doi: 10.1111/jvh.13941.
    >> Share

  326. MESZAROS M, Coursier S, Nagot N, Moulis L, et al
    Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
    J Viral Hepat. 2024 May 15. doi: 10.1111/jvh.13947.
    >> Share

  327. ROUSSOS S, Bagos C, Angelopoulos T, Chaikalis S, et al
    Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
    J Viral Hepat. 2024 May 14. doi: 10.1111/jvh.13951.
    >> Share

  328. ZHONG W, Zheng J, Yao N, Feng Y, et al
    Association of HBeAg decline rate from mid-pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus-infected mothers.
    J Viral Hepat. 2024 May 10. doi: 10.1111/jvh.13948.
    >> Share

  329. KUMAR A, Sahu U, Agnihotri G, Dixit A, et al
    A novel multi-epitope peptide vaccine candidate targeting hepatitis E virus: An in silico approach.
    J Viral Hepat. 2024 May 10. doi: 10.1111/jvh.13949.
    >> Share

  330. MAK LY, Yee LJ, Wong RJ, Ramers CB, et al
    Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase.
    J Viral Hepat. 2024 May 8. doi: 10.1111/jvh.13914.
    >> Share

  331. RAZAVI-SHEARER D
    The economic argument for hepatitis B treatment simplification and expansion.
    J Viral Hepat. 2024 May 8. doi: 10.1111/jvh.13920.
    >> Share

    April 2024
  332. ALI M, Tucker JD, Kpokiri EE, Wu D, et al
    Crowdsourcing to increase hepatitis B and C testing and reduce hepatitis stigma among medical students in Bangladesh.
    J Viral Hepat. 2024 Apr 28. doi: 10.1111/jvh.13945.
    >> Share

  333. HOLT B, Mendoza J, Nguyen H, Doan D, et al
    Barriers and enablers to people-centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study.
    J Viral Hepat. 2024 Apr 23. doi: 10.1111/jvh.13944.
    >> Share

  334. ALQAHTANI SA, Yilmaz Y, El-Kassas M, Alswat K, et al
    Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935.
    >> Share

  335. WONG RJ, Hirode G, Feld J, Wong SS, et al
    An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13939.
    >> Share

  336. OLTMANNS C, Bremer B, Kusche L, Stal P, et al
    Elevation of S2-bound alpha1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
    J Viral Hepat. 2024 Apr 12. doi: 10.1111/jvh.13943.
    >> Share

  337. RUI F, Garcia E, Hu X, Ni W, et al
    Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta-analysis.
    J Viral Hepat. 2024 Apr 8. doi: 10.1111/jvh.13942.
    >> Share

  338. SARAVANAN S, Shankar EM, Vignesh R, Ganesh PS, et al
    Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication.
    J Viral Hepat. 2024 Apr 5. doi: 10.1111/jvh.13928.
    >> Share

  339. MAINA A, Foster GR
    Hepatitis after gene therapy, what are the possible causes?
    J Viral Hepat. 2024;31 Suppl 1:14-20.
    >> Share

    March 2024
  340. GUPTA N, Swindells S, Scarsi KK, Furl R, et al
    Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers.
    J Viral Hepat. 2024 Mar 28. doi: 10.1111/jvh.13921.
    >> Share

  341. NAVEED A, Khalid A, Janjua N, Cloherty GA, et al
    Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population.
    J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13937.
    >> Share

  342. DOBROWOLSKA K, Pawlowska M, Zarebska-Michaluk D, Rzymski P, et al
    Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
    J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13936.
    >> Share

  343. HAVENS JR, Lofwall MR, Young AM, Staton M, et al
    Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community.
    J Viral Hepat. 2024 Mar 4. doi: 10.1111/jvh.13933.
    >> Share

  344. SULKOWSKI MS, Martinez A, Tyson GL, Scholz K, et al
    Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs.
    J Viral Hepat. 2024 Mar 3. doi: 10.1111/jvh.13927.
    >> Share

    February 2024
  345. KATCHER JG, Klassen AC, Hann HW, Chang M, et al
    Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B-related stigma among patients with chronic hepatitis B.
    J Viral Hepat. 2024 Feb 26. doi: 10.1111/jvh.13932.
    >> Share

  346. IQBAL HS, Gunaratne MP, Loeb TA, Pradeep A, et al
    High prevalence of hepatitis B virus among MSM living with HIV in India.
    J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13929.
    >> Share

  347. WOLFSON-STOFKO B, Hirode G, Vanderhoff A, Karkada J, et al
    Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada.
    J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13931.
    >> Share

  348. FRYE K, Davis A, Darby R, McDaniel K, et al
    A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety-net hospital.
    J Viral Hepat. 2024 Feb 18. doi: 10.1111/jvh.13913.
    >> Share

  349. WALTER LA, Prados M, Lloyd A, Sontheimer S, et al
    Birth cohort-specific consideration in an Emergency Department Hepatitis C Testing Programme: A description of age-related characteristics and outcomes.
    J Viral Hepat. 2024 Feb 17. doi: 10.1111/jvh.13930.
    >> Share

  350. TULLY DC, Power KA, Sarette J, Stopka TJ, et al
    Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance.
    J Viral Hepat. 2024 Feb 16. doi: 10.1111/jvh.13924.
    >> Share

  351. WU L, Yang Z, Zheng M
    Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy.
    J Viral Hepat. 2024 Feb 8. doi: 10.1111/jvh.13926.
    >> Share

  352. EPSTEIN RL, Buzzee B, White LF, Feld JJ, et al
    Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus.
    J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13925.
    >> Share

  353. LV R, Lu Y, Xiang W, Meng M, et al
    Chronic viral hepatitis C micro-elimination program using telemedicine in Guigang city.
    J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13922.
    >> Share

    January 2024
  354. FARAG MS, van Campenhout MJH, Sonneveld MJ, Fung S, et al
    Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
    J Viral Hepat. 2024 Jan 19. doi: 10.1111/jvh.13918.
    >> Share

  355. POLLOCK TS, Robert CA, Seybold DJ, Hur M, et al
    Prevalence of hepatitis C among pregnant women in an Appalachian population.
    J Viral Hepat. 2024 Jan 18. doi: 10.1111/jvh.13911.
    >> Share

  356. QIN W, Shao L, Wang J, Zhang H, et al
    Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real-world data.
    J Viral Hepat. 2024 Jan 18. doi: 10.1111/jvh.13908.
    >> Share

  357. HIBBERT M, Simmons R, Sabin CA, Mandal S, et al
    Identifying missed opportunities for hepatitis C virus antenatal testing and diagnosis in England.
    J Viral Hepat. 2024 Jan 4. doi: 10.1111/jvh.13906.
    >> Share

  358. QURESHI H, Duran AC, Mahmood H, Sarwar Z, et al
    Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurement.
    J Viral Hepat. 2024 Jan 2. doi: 10.1111/jvh.13910.
    >> Share

  359. HIGE S, Aoki K, Nakamoto D, Flaherty JF, et al
    Real-world safety and effectiveness of tenofovir alamenamide for 144 weeks in Japanese patients with chronic hepatitis B.
    J Viral Hepat. 2024 Jan 1. doi: 10.1111/jvh.13912.
    >> Share

    December 2023
  360. ALQAHTANI SA, Stepanova M, Al Shabeeb R, Eberly KL, et al
    The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States.
    J Viral Hepat. 2023 Dec 29. doi: 10.1111/jvh.13916.
    >> Share

  361. O'KEEFE D, Jacka D, Douglass C, Gunn J, et al
    Distribution of rapid HCV antibody self-test kits via needle/syringe dispensing machines: Implementation and evaluation of the Vend-C pilot study in Melbourne, Australia.
    J Viral Hepat. 2023 Dec 29. doi: 10.1111/jvh.13909.
    >> Share

  362. TOYODA H, Koshiyama Y, Yasuda S, Kumada T, et al
    Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2023 Dec 26. doi: 10.1111/jvh.13907.
    >> Share

  363. WAN Y, Mao M, Li M, Liu J, et al
    Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B.
    J Viral Hepat. 2023 Dec 25. doi: 10.1111/jvh.13905.
    >> Share

  364. ZHOU S, Qi K, Bersoff-Matcha SJ, Mishra P, et al
    Sex-related difference analyses of efficacy and safety in clinical trials of direct-acting antivirals to treat chronic HCV genotype 1 and 3 infections.
    J Viral Hepat. 2023 Dec 19. doi: 10.1111/jvh.13901.
    >> Share

  365. YANG Q, Lin T, Zhao Y, Qiu Y, et al
    International disease burden of acute viral hepatitis among adolescents and young adults: An observational study.
    J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13903.
    >> Share

  366. WASUWANICH P, So JM, Rajborirug S, Karnsakul W, et al
    Hepatitis A hospitalisations in the United States and risk factors for inpatient mortality: A nationwide population study, 1998-2020.
    J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13902.
    >> Share

  367. RAZAVI H, Blach S, Bregenzer A, Bruggmann P, et al
    Assessing the hepatitis C epidemiology in Switzerland: It is not that trivial.
    J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13904.
    >> Share

  368. NING Q, Yang T, Guo X, Huang Y, et al
    CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes.
    J Viral Hepat. 2023;30:951-958.
    >> Share

    November 2023
  369. O'SULLIVAN M, Jones AM, Mourad A, Haddadin Y, et al
    Excellent hepatitis C virus cure rates despite increasing complexity of people who use drugs: Integrated-Test-stage Treat study final outcomes.
    J Viral Hepat. 2023 Nov 28. doi: 10.1111/jvh.13897.
    >> Share

  370. DEMIREL A, Uraz S, Deniz Z, Daglilar E, et al
    Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
    J Viral Hepat. 2023 Nov 14. doi: 10.1111/jvh.13899.
    >> Share

  371. HAJARIZADEH B, Carson JM, Byrne M, Grebely J, et al
    Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
    J Viral Hepat. 2023 Nov 7. doi: 10.1111/jvh.13895.
    >> Share

  372. NATOUR RT, Midlej A, Mahajna E, Kopelman Y, et al
    Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on quality of life.
    J Viral Hepat. 2023 Nov 3. doi: 10.1111/jvh.13894.
    >> Share

  373. TRELOAR C, Rance J, Bryant J, Lafferty L, et al
    "There's too much power in this number. It's freaking the whole response out": the views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia.
    J Viral Hepat. 2023 Nov 2. doi: 10.1111/jvh.13896.
    >> Share

    October 2023
  374. MAK LY, Koffas A, Dolman GE, Saleh H, et al
    Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi-ethnic cohort.
    J Viral Hepat. 2023 Oct 26. doi: 10.1111/jvh.13893.
    >> Share

  375. BERTISCH B, Schaetti C, Schmid P, Peter L, et al
    Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.
    J Viral Hepat. 2023 Oct 7. doi: 10.1111/jvh.13892.
    >> Share

  376. VANWOLLEGHEM T, Armstrong PA, Buti M, FitzSimons D, et al
    The elimination of hepatitis D as a public health problem: Needs and challenges.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13891.
    >> Share

  377. VIRTUDAZO MCC, Aquino JB, Arellano RNB, Fortes RA, et al
    The role of dried blood spot tests in the detection of hepatitis B infection: A systematic review.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13890.
    >> Share

  378. BEGHIN J, Meier-Stephenson V
    Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13889.
    >> Share

    September 2023
  379. MA NZ, Dai W, Bao X, Bu ZQ, et al
    Effects of hepatitis B virus infection on the treatment outcomes following in vitro fertilization/intracytoplasmic sperm injection: An analysis of 21,999 first embryo transfer cycles.
    J Viral Hepat. 2023 Sep 23. doi: 10.1111/jvh.13878.
    >> Share

  380. EVANS KN, Vettese T, Wortley PM, Gandhi AP, et al
    HIV and HCV testing at clinical encounters among people who inject drugs, 2013-2018-Opportunities for increased testing and prevention.
    J Viral Hepat. 2023 Sep 19. doi: 10.1111/jvh.13877.
    >> Share

  381. HE H, Wu Y, Jia Z, Xu H, et al
    Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-up.
    J Viral Hepat. 2023 Sep 18. doi: 10.1111/jvh.13884.
    >> Share

  382. CAROLINE A, Kate M, Roberts M, Ryan J, et al
    What is the impact of a Hepatitis C 'test, trace and treat' pilot using peer workers?
    J Viral Hepat. 2023 Sep 18. doi: 10.1111/jvh.13888.
    >> Share

  383. JOHNSON A, Shearer J, Thompson C, Jelley R, et al
    Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
    J Viral Hepat. 2023 Sep 12. doi: 10.1111/jvh.13887.
    >> Share

  384. KHAN S, Kumar Y, Sharma C, Gupta SK, et al
    Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study.
    J Viral Hepat. 2023 Sep 11. doi: 10.1111/jvh.13885.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016